Even though it’s no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure.
Essure birth control device tied to higher rates of pain and bleeding, FDA says
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push